REGENXBIO Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
![]() CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
![]() FDMT
4D Molecular Therapeutics, Inc. |
$6.35 | $1.17 B | -9.63 | 147 | $37,000 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() IMCR
Immunocore Holdings plc |
$29.87 | $2.08 B | -26.72 | 493 | $310.20 M |
![]() KZR
Kezar Life Sciences, Inc. |
$6.65 | $49.85 M | -0.49 | 58 | $7.00 M |
![]() LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 | $0 |
![]() MIRM
Mirum Pharmaceuticals, Inc. |
$43.09 | $1.18 B | -6.7 | 322 | $336.89 M |
![]() PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
![]() PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
![]() PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
![]() QURE
uniQure N.V. |
$18.08 | $258.77 M | -0.86 | 209 | $27.12 M |
![]() RCKT
Rocket Pharmaceuticals, Inc. |
$12.35 | $2.06 B | -7.96 | 299 | $0 |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() RNA
Avidity Biosciences, Inc. |
$31.42 | $2.54 B | -8.99 | 391 | $10.90 M |
![]() RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
![]() STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |